First Page | Document Content | |
---|---|---|
Date: 2011-12-08 14:49:32Anatomy Hereditary angioedema Angioedema C1-inhibitor Simvastatin Hypogonadism Danazol Tuberculosis treatment Complement deficiency Health Medicine | et al. Clinical and Experimental Immunology REVIEWAdd to Reading ListSource URL: www.haeuk.orgDownload Document from Source WebsiteFile Size: 189,98 KBShare Document on Facebook |
[Product Monograph Template - Schedule D]DocID: 1qWQL - View Document | |
News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites ÂDocID: 1qHpD - View Document | |
Microsoft Word - CINRYZE.Product MonographdocDocID: 1qE2h - View Document | |
Microsoft Word - FIRAZYR.Product MonographdocDocID: 1qA9x - View Document | |
Fact Sheet CSL BehringCSL Sales $5.5 Billion CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we developDocID: 1pVHk - View Document |